Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Merck Sharp & Dohme B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 5, 2025
Approval ID: 8d51ab9c98c9d502
Company: Merck Sharp & Dohme B.V.
Type: Standard

Approval Details

Approval Id: 8d51ab9c98c9d502
Drug Cima Aemps Name: WELIREG 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1241893002
Holder Company Name: Merck Sharp & Dohme B.V.
Marketing Company Name: Merck Sharp & Dohme De Espana S.A.
Holder Company Detail Path: /organization/26790a8059eb4c1e/merck-sharp-and-dohme-bv
Authorization Date: 2025-03-05
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: No
Company Name: Merck Sharp & Dohme B.V.
Company Detail Path: /organization/26790a8059eb4c1e/merck-sharp-and-dohme-bv

Company Information

Pharmaceutical Company Name: Merck Sharp & Dohme BV
Country Name: Netherlands

Active Ingredients

BELZUTIFAN

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 5, 2025

Approval ID

8d51ab9c98c9d502

Type

Standard

Back to CIMA-AEMPS Approvals